do-me/EUR-LEX huggingface dataset:
Case T-63/23: Judgment of the General Court of 10 April 2024 – Maxeon Solar v EUIPO – ZO(Solar panels (part of -))
Date: 2024-04-10
Institutions: General Court
Subjects: designs and models, photovoltaic cell, solar collector








C_202403331EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3331


3.6.2024






Judgment of the General Court of 10 April 2024 – Maxeon Solar v EUIPO – ZO(Solar panels (part of -))


(Case T-63/23)
                (1)

(Community design - Invalidity proceedings - Registered Community design representing part of solar panels - Earlier design - Ground for invalidity - No individual character - Informed user - No different overall impression - Article 6 of Regulation (EC) No 6/2002)
(C/2024/3331)
Language of the case: English

Parties


Applicant: Maxeon Solar Pte. Ltd (Singapore, Singapore) (represented by: U. Lüken and J. Bärenfänger, lawyers, authorised to replace SunPower Corporation)

Defendant: European Union Intellectual Property Office (represented by: J. Hamel and J. Ivanauskas, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: ZO

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment and alteration of the decision of the Third Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 9 December 2022 (Case R 1589/2021-3).

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders Maxeon Solar Pte. Ltd to pay the costs.






(1)  
            OJ C 121, 3.4.2023.


ELI: http://data.europa.eu/eli/C/2024/3331/oj
ISSN 1977-091X (electronic edition)
P9_TA(2024)0214 – Agreement between the European Union and the Kingdom of Norway on supplementary rules in relation to the instrument for financial support for border management and visa policy, as part of the Integrated Border Management Fund – European Parliament legislative resolution of 10 April 2024 on the draft Council decision on the conclusion, on behalf of the Union, of the Agreement between the European Union and the Kingdom of Norway on supplementary rules in relation to the Instrument for Financial Support for Border Management and Visa Policy, as part of the Integrated Border Management Fund, for the period 2021 to 2027 (12129/2023 – C9-0002/2024 – 2023/0224(NLE)) (Consent)
Date: 2024-04-10
Institutions: Committee on Civil Liberties, Justice and Home Affairs, European Parliament
Subjects: EU migration policy, EU visa policy, Norway, Schengen Agreement, agreement (EU), border control, external border of the EU, fund (EU), ratification of an agreement








C_202501322EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/1322


13.3.2025






P9_TA(2024)0214

Agreement between the European Union and the Kingdom of Norway on supplementary rules in relation to the instrument for financial support for border management and visa policy, as part of the Integrated Border Management Fund


European Parliament legislative resolution of 10 April 2024 on the draft Council decision on the conclusion, on behalf of the Union, of the Agreement between the European Union and the Kingdom of Norway on supplementary rules in relation to the Instrument for Financial Support for Border Management and Visa Policy, as part of the Integrated Border Management Fund, for the period 2021 to 2027 (12129/2023 – C9-0002/2024 – 2023/0224(NLE))


(Consent)

(C/2025/1322)



The European Parliament,






—


having regard to the draft Council decision (12129/2023),










—


having regard to the draft Agreement between the European Union and the Kingdom of Norway on supplementary rules in relation to the Instrument for Financial Support for Border Management and Visa Policy, as part of the Integrated Border Management Fund, for the period 2021 to 2027 (12128/2023),










—


having regard to the request for consent submitted by the Council in accordance with Article 77(2), Article 218(6), second subparagraph, point (a), and Article 218(7) of the Treaty on the Functioning of the European Union (C9-0002/2024),










—


having regard to Rule 105(1) and (4), and Rule 114(7) of its Rules of Procedure,










—


having regard to the recommendation of the Committee on Civil Liberties, Justice and Home Affairs (A9-0143/2024),











1.


Gives its consent to the conclusion of the agreement;










2.


Instructs its President to forward its position to the Council, the Commission and the governments and parliaments of the Member States and of the Kingdom of Norway.






ELI: http://data.europa.eu/eli/C/2025/1322/oj
ISSN 1977-091X (electronic edition)
Case T-279/22: Order of the General Court of 10 April 2024 – Biogen Netherlands v Commission
Date: 2024-04-10
Institutions: General Court
Subjects: drug surveillance, generic drug, market approval








C_202403617EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3617


17.6.2024






Order of the General Court of 10 April 2024 – Biogen Netherlands v Commission


(Case T-279/22)
                (1)

(Action for annulment - Public health - Medicinal products for human use - Decision to grant marketing authorisation for Dimethyl fumarate Mylan - dimethyl fumarate - Repeal of the contested decision - Action which has become devoid of purpose - No need to adjudicate)
(C/2024/3617)
Language of the case: English

Parties


Applicant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek, lawyer)

Defendant: European Commission (represented by: K. Mifsud Bonnici, A. Sipos and E. Mathieu, acting as Agents)

Intervener in support of the defendant: Mylan Ireland Ltd (Dublin, Ireland) (represented by: C. Dekoninck, lawyer)

Re:

By its application based on Article 263 TFEU, the applicant seeks annulment of Commission Implementing Decision C(2022) 3252 final of 13 May 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for Dimethyl fumarate Mylan – dimethyl fumarate as a medicinal product for human use.

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


Biogen Netherlands BV and the European Commission shall bear their own costs, including those relating to the proceedings for interim measures and to the application to intervene of Mylan Ireland Ltd.










3.


Mylan Ireland shall bear its own costs relating to the application to intervene.






(1)  
            OJ C 284, 25.7.2022.


ELI: http://data.europa.eu/eli/C/2024/3617/oj
ISSN 1977-091X (electronic edition)
Case T-22/22: Judgment of the General Court of 10 April 2024 - AL v Council
Date: 2024-04-10
Institutions: General Court
Subjects: European Anti-fraud Office, European official, administrative sanction, disciplinary proceedings, dismissal, principle of proportionality, staff regulations (EU)








C_202403320EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3320


3.6.2024






Judgment of the General Court of 10 April 2024 - AL v Council


(Case T-22/22)
                (1)

(Civil service - Officials - Disciplinary proceedings - Disciplinary penalty - Removal from post - OLAF investigation - Principle of sound administration - Article 22 of Annex IX to the Staff Regulations - Obligation to state reasons - Manifest error of assessment - Article 10 of Annex IX to the Staff Regulations - Proportionality - Legitimate expectations - Duty to have regard for the welfare of officials)
(C/2024/3320)
Language of the case: English

Parties


Applicant: AL (represented by: R. Rata, lawyer)

Defendant: Council of the European Union (represented by: M. Bauer and M. Alver, acting as Agents)

Re:

By his action based on Article 270 TFEU, the applicant, AL, seeks annulment of the decision of 27 September 2021 of the Council of the European Union, by which he was removed from his post.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders AL to pay the costs of the present proceedings;










3.


Orders the Council of the European Union to pay the costs relating to the proceedings for interim measures.






(1)  
            OJ C 109, 7.3.2022.


ELI: http://data.europa.eu/eli/C/2024/3320/oj
ISSN 1977-091X (electronic edition)
Case T-38/23: Judgment of the General Court of 10 April 2024 – IB v EUIPO
Date: 2024-04-10
Institutions: General Court
Subjects: European official, administrative sanction, disabled person, disciplinary proceedings, termination of employment, worker with disabilities








C_202403328EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3328


3.6.2024






Judgment of the General Court of 10 April 2024 – IB v EUIPO


(Case T-38/23)
                (1)

(Civil service - Officials - Total and permanent invalidity - Refusal to resume the invalidity procedure - Article 266 TFEU - Decision adopted to give effect to a judgment of the General Court - Measures necessary to give effect to a judgment delivered in an action for annulment - Disciplinary proceedings - Removal from post - Liability)
(C/2024/3328)
Language of the case: French

Parties


Applicant: IB (represented by: N. de Montigny, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO) (represented by: A. Lukošiūtė, E. Lekan and D. Botis, acting as Agents, and by B. Wägenbaur, lawyer)

Re:

By his action based on Article 270 TFEU, the applicant seeks, in essence, first, the annulment of the decision of the European Union Intellectual Property Office (EUIPO) of 11 April 2022 adopted to give effect to the judgment of 13 October 2021, IB v EUIPO (T-22/20, EU:T:2021:689) and, in so far as necessary, of the decision of 2 November 2022 rejecting the complaint against the decision of 11 April 2022, second, principally, compensation for the damage suffered as a result of that decision or, in the alternative, that EUIPO be ordered to resume the invalidity procedure and, third, that the third doctor on the Invalidity Committee be appointed ex officio.

Operative part of the judgment

The Court:






1.


Annuls the decision of the European Union Intellectual Property Office (EUIPO) of 11 April 2022 giving effect to the judgment of 13 October 2021, IB v EUIPO (T-22/20);










2.


Orders EUIPO to pay IB the sum of EUR 4 000 in respect of the non-material damage suffered;










3.


Dismisses the action as to the remainder;










4.


Orders EUIPO to bear its own costs and to pay those incurred by IB, and to refund to the Court cashier the sums advanced by way of legal aid.






(1)  
            OJ C 223, 26.6.2023.


ELI: http://data.europa.eu/eli/C/2024/3328/oj
ISSN 1977-091X (electronic edition)
Case T-42/23: Judgment of the General Court of 10 April 2024 – Häcker Küchen v EUIPO – Moura & Moura (MH Cuisines)
Date: 2024-04-10
Institutions: General Court
Subjects: EU trade mark, decorative item, electronic commerce, furniture industry, registered trade mark, retail trade, textile product, trade-mark law, wholesale trade








C_202403329EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3329


3.6.2024






Judgment of the General Court of 10 April 2024 – Häcker Küchen v EUIPO – Moura & Moura (MH Cuisines)


(Case T-42/23)
                (1)

(EU trade mark - Opposition proceedings - Application for EU figurative mark MH Cuisines - International registration of the earlier figurative mark MM CUISINES - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
(C/2024/3329)
Language of the case: German

Parties


Applicant: Häcker Küchen GmbH & Co. KG (Rödinghausen, Germany) (represented by: F. Dehn, L. Maritzen, C. Krafft and K. Blükle, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Bosse and T. Klee, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Moura & Moura & Moura Fabricação e Comercialização de Mobiliário Lda (Sanfins de Ferreira, Portugal)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 24 November 2022 (Case R 1078/2022-1).

Operative part of the judgment

The Court:






1.


Annuls the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 24 November 2022 (Case R 1078/2022-1);










2.


Orders EUIPO to pay the costs.






(1)  
            OJ C 104, 20.3.2023.


ELI: http://data.europa.eu/eli/C/2024/3329/oj
ISSN 1977-091X (electronic edition)
Case T-269/22: Order of the General Court of 10 April 2024 – Biogen Netherlands v Commission
Date: 2024-04-10
Institutions: General Court
Subjects: drug surveillance, generic drug, market approval








C_202403615EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3615


17.6.2024






Order of the General Court of 10 April 2024 – Biogen Netherlands v Commission


(Case T-269/22)
                (1)

(Action for annulment - Public health - Medicinal products for human use - Decision to grant marketing authorisation for Dimethyl fumarate Polpharma - dimethyl fumarate - Repeal of the contested decision - Action which has become devoid of purpose - No need to adjudicate)
(C/2024/3615)
Language of the case: English

Parties


Applicant: Biogen Netherlands BV (Amsterdam, Netherlands) (represented by: C. Schoonderbeek and B. Jong, lawyers)

Defendant: European Commission (represented by: K. Mifsud-Bonnici, A. Sipos and E. Mathieu, acting as Agents)

Re:

By its application based on Article 263 TFEU, the applicant seeks annulment of Commission Implementing Decision C(2022) 3253 final of 13 May 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for Dimethyl fumarate Polpharma – dimethyl fumarate as a medicinal product for human use.

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


Biogen Netherlands BV and the European Commission shall bear their own costs, including those relating to the proceedings for interim measures.






(1)  
            OJ C 284, 25.7.2022.


ELI: http://data.europa.eu/eli/C/2024/3615/oj
ISSN 1977-091X (electronic edition)
Case T-1043/23: Order of the General Court of 10 April 2024 – momox v EUIPO – Nyky (momox FASHION)
Date: 2024-04-10
Institutions: General Court
Subjects: EU trade mark, advertising, clothing, electronic commerce, hairdressing and beauty care, leather industry, registered trade mark, software, telecommunications, trade-mark law, waste recycling








C_202403337EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3337


3.6.2024






Order of the General Court of 10 April 2024 – momox v EUIPO – Nyky (momox FASHION)


(Case T-1043/23)
                (1)

(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)
(C/2024/3337)
Language of the case: English

Parties


Applicant: momox SE (Berlin, Germany) (represented by: U. Lüken, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Hanf, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Nyky Srl (Silea, Italy)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 17 August 2023 (Case R 139/2023-1).

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


Each party shall bear its own costs.






(1)  
            OJ C C/2023/1179, 4.12.2023.


ELI: http://data.europa.eu/eli/C/2024/3337/oj
ISSN 1977-091X (electronic edition)